Advancing Science, Transforming Lives: Explore Bayer’s Clinical Trials

Bayer Clinical Trial Explorer

This website provides publicly available information on Bayer‑sponsored clinical trials conducted worldwide. It includes details on ongoing and completed trials
, as well as lay summaries of clinical trial results
, presented in an accessible format for patients, healthcare professionals, and the general public.

Explore Bayer clinical trials that are currently recruiting participants

medium sized icon representing the Cardiovascular area of interest

Heart, Blood and Kidney Disorders

See Heart and Blood Trials

small sized icon representing the Oncology area of interest

Cancer

See Cancer Trials

medium sized icon representing the Ophthalmology area of interest

Eye Disorders

See Eye Disorders Trials

medium sized icon representing the Women's Health area of interest

Women's Health and Birth Control

See Women's Health Trials

See Kidney Disorders Trials

What Are Clinical Trials?

ABOUT CLINICAL TRIALS

Clinical trials are needed to find new medicines for the patients that need them.

PHASES OF CLINICAL TRIALS

Clinical Trials are conducted in several steps, called phases.

FREQUENTLY ASKED QUESTIONS

If you would like to learn more about clinical trials we provide you with answers to frequently asked questions.

Summaries of Clinical Trial Results in Lay Language

At Bayer, we understand that navigating the world of clinical trials can be overwhelming, especially with all the technical terms involved. That's why we've made it our mission to present information in a way that is easy to understand for everyone.

Find easy-to-understand summaries of Bayer’s oncology clinical trials, created by patients for patients

. We believe in transparency and supporting your healthcare decisions. You will find links to the original journal articles where these plain language summaries are published, making it simple for you to access clear and reliable information about research that matters to you. Our goal is to help you stay informed and empowered in your health journey.

Click here to access our PLSP

Our Partner Companies – United by Passion to maximize value creation by improving patient lives

At Bayer we are committed to revolutionizing healthcare through innovative solutions. Co-creation between

Bayer

and its partner platform companies
is vital for driving innovation and achieving significant sustainable impact, as collaboration enables resource optimization and expanded reach. This partnership fosters synergetic expertise and opens new opportunities, ultimately leading to greater value creation.

AskBio

is a pioneering gene therapy company that utilizes advanced delivery systems to precisely target and treat specific cells in the body. This approach holds the potential for more effective treatments for a range of diseases.

Learn more about AskBio

BlueRock Therapeutics

is a clinical stage cell therapy company focused on creating cellular medicines to treat devastating diseases. We are harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases.

Learn more about BlueRock

Vividion Therapeutics

enhances our capabilities in drug discovery by leveraging their proprietary platform to identify and develop small-molecule therapies that target previously inaccessible proteins. This collaboration expands our reach into new therapeutic areas.

Learn more about Vividion

Together with

AskBio

, BlueRock
, and Vividion
, Bayer
is harnessing cutting-edge research and technology to bring transformative therapies to patients in need. We believe in the power of science to change lives, and we are excited to lead the way in this groundbreaking field.

Join us on this journey towards a healthier future!

If you want to learn more about benefits and risks of medicines, the Bayer's Patient Knowledge Tour page provides you with some useful information on the benefits and risks of drugs and how they are researched, developed, and continuously monitored and evaluated for safety.

Our Efforts To Be Transparent About Clinical Trials

Bayer is fully committed to make information about its planned and ongoing clinical trials publically available. This is done in line with the position of the global pharmaceutical industry associations and related laws. Bayer will also make results of trials in patients public and provide free access to this information on the internet, irrespective of whether the results of a trial for one of our products are positive or negative.

Bayer is committed to sharing of study patient data with qualified researchers as a transparency measure to advance medical knowledge and public health and foster scientific discovery. Data sharing is following international standards to protect patient’s data privacy.

Bayer provides free access to study plans and to results of clinical studies on several publically accessible Clinical Trial Registries on the internet.

To access information on Bayer Trials, please visit the Bayer Clinical Trials Explorer page. To read the complete Bayer Clinical Trial Transparency Policy, please click “read more” below.